News
An incidental finding in prostate biopsies allows the diagnosis of a previously unsuspected systemic disease
The research, led by researchers from IDIBELL and the Bellvitge University Hospital (HUB), has established that when amyloidosis is detected in the prostate, it is almost always the TTR-type systemic variant of the disease associated with aging.
Tobacco control in the 21st century: A global and local perspective
Among recent achievements, first of all, the entry into force of the WHO Framework Convention on Tobacco Control in 2005 stands out, which has surely been the most important milestone, not only for tobacco control, but as a paradigm of public health on a global scale.
Five IDIBELL researchers star in the Women of Science section of the television program Aula L’H
The Aula L’H program on L’Hospitalet digital television, specialized in education, together with the Institut Bellvitge and IDIBELL, have carried out, throughout the 2021-22 academic year, a complete edition of the Women of Science section, entirely dedicated to disseminating the research work, the research career and the personality of five IDIBELL scientists.
Validated a tool that assesses the risk of sudden death due to a heart disease
Twenty-nine reference centers from the United States, Canada, the Netherlands, Italy, France, and Spain, including IDIBELL, have participated in an international multicenter study that validated a model for predicting the risk of ventricular arrhythmias and sudden death in arrhythmogenic cardiomyopathy of the right ventricle (ARVC).
A study of IDIBELL and IDIBGI evaluates the efficacy of an anti-tumour drug against obesity
The drug inhibits the S6K1 protein, which is essential for the development of new fat cells, responsible for the disproportionate growth of fat deposits in obese people.
A generic antiviral could improve the life expectancy of patients with a rare disease without a cure
IDIBELL and Hospital de Bellvitge are studying the efficacy of Efavirenz, an antiretroviral against HIV, for the treatment of Niemann Pick type C in a clinical trial.
Two out of Three Women Between 30 and 49 Years of Age Have Never Been Screened for Cervical Cancer
A new study produces comparable estimates of screening coverage for 202 countries and territories
AtG Therapeutics completes a seed financing round raising more than half a million euros
The spin-off that emerged from IDIBELL and the Catalan Institute of Oncology is developing new therapeutic alternatives for advanced cancers and a screening system for these patients.
White adipose tissue is the most vulnerable to metabolic changes caused by obesity
The study, based on an animal experimental model, shows that when physiological stress exceeds the capacity of white adipose tissue to respond, it reaches a point of no return where it loses its metabolic plasticity.